<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04729920</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01114</org_study_id>
    <nct_id>NCT04729920</nct_id>
  </id_info>
  <brief_title>Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases</brief_title>
  <official_title>Predictors of Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Patients: a Cross-sectional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ligue Pulmonaire Vaudoise</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      With this cross-sectional study of adult subjects with neuromuscular disease in the&#xD;
      French-speaking part of Switzerland, we aim to explore MI-E adherence using self-report&#xD;
      questionnaires and device data in order to identify the factors that influence the pattern of&#xD;
      MI-E use and satisfaction with the treatment. Determining potential barriers to regular&#xD;
      long-term home use of MI-E could help in identifying the patients who would benefit most from&#xD;
      this therapy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 15, 2019</start_date>
  <completion_date type="Actual">May 1, 2020</completion_date>
  <primary_completion_date type="Actual">May 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to MI-E (reported)</measure>
    <time_frame>12 months, or since treatment initiation (&gt; 3 months)</time_frame>
    <description>based on self-reported use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence to MI-E (objective)</measure>
    <time_frame>12 months, or since treatment initiation (&gt; 3 months)</time_frame>
    <description>based on data downloads</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with the device</measure>
    <time_frame>12 months, or since treatment initiation (&gt; 3 months)</time_frame>
    <description>Self-report questionnaire</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">43</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <arm_group>
    <arm_group_label>subjects with neuromuscular disease</arm_group_label>
    <description>Adult subjects with neuromuscular disease, with an active prescription of MI-E for more than 3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mechanical insufflation/exsufflation device (MI-E)</intervention_name>
    <description>download of device (MI-E) data and self-reported satisfaction with the device</description>
    <arm_group_label>subjects with neuromuscular disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult subjects with neuromuscular disease, with an active prescription of MI-E for more&#xD;
        than 3 months&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age over 18 years&#xD;
&#xD;
          -  Diagnosis of neuromuscular disease&#xD;
&#xD;
          -  Active prescription of MI-E for more than 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -Invasive airway&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Service de Pneumologie, CHUV</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 31, 2021</last_update_submitted>
  <last_update_submitted_qc>January 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>GEORGIA MITROPOULOU</investigator_full_name>
    <investigator_title>Cheffe de clinique</investigator_title>
  </responsible_party>
  <keyword>Mechanical insufflation-exsufflation</keyword>
  <keyword>Cough assistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

